Literature DB >> 9973401

Distinct effects of Jak3 signaling on alphabeta and gammadelta thymocyte development.

E E Eynon1, F Livák, K Kuida, D G Schatz, R A Flavell.   

Abstract

Janus kinase 3 (Jak3) plays a central role in the transduction of signals mediated by the IL-2 family of cytokine receptors. Targeted deletion of the murine Jak3 gene results in severe reduction of alphabeta and complete elimination of gammadelta lineage thymocytes and NK cells. The developmental blockade appears to be imposed on early thymocyte differentiation and/or expansion. In this study, we show that bcl-2 expression and in vivo survival of immature thymocytes are greatly compromised in Jak3-/- mice. There is no gross deficiency in rearrangements of the TCRdelta and certain gamma loci in pre-T cells, and a functional gammadelta TCR transgene cannot rescue gammadelta lineage differentiation in Jak3-/- mice. In contrast, a TCRbeta transgene is partially able to restore alphabeta thymocyte development. These data suggest that the signals mediated by Jak3 are critical for survival of all thymocyte precursors particularly during TCRbeta-chain gene rearrangement, and are continuously required in the gammadelta lineage. The results also emphasize the fundamentally different requirements for differentiation of the alphabeta and gammadelta T cell lineages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

2.  Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches.

Authors:  K Laky; L Lefrançois; E G Lingenheld; H Ishikawa; J M Lewis; S Olson; K Suzuki; R E Tigelaar; L Puddington
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

Review 3.  Stem Cell-Based Disease Models for Inborn Errors of Immunity.

Authors:  Aline Zbinden; Kirsten Canté-Barrett; Karin Pike-Overzet; Frank J T Staal
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.